CCDC88B interacts with RASAL3 and ARHGEF2 and regulates dendritic cell function in neuroinflammation and colitis

Jean-Frederic Olivier,David Langlais,Thiviya Jeyakumar,Maria J. Polyak,Luc Galarneau,Romain Cayrol,Hua Jiang,Kelly R. Molloy,Guoyue Xu,Harumi Suzuki,John LaCava,Philippe Gros,Nassima Fodil
DOI: https://doi.org/10.1038/s42003-023-05751-9
IF: 6.548
2024-01-11
Communications Biology
Abstract:CCDC88B is a risk factor for several chronic inflammatory diseases in humans and its inactivation causes a migratory defect in DCs in mice. CCDC88B belongs to a family of cytoskeleton-associated scaffold proteins that feature protein:protein interaction domains. Here, we identified the Rho/Rac Guanine Nucleotide Exchange Factor 2 (ARHGEF2) and the RAS Protein Activator Like 3 (RASAL3) as CCDC88B physical and functional interactors. Mice defective in Arhgef2 or Rasal3 show dampened neuroinflammation, and display altered cellular response and susceptibility to colitis; ARHGEF2 maps to a human Chromosome 1 locus associated with susceptibility to IBD. Arhgef2 and Rasal3 mutant DCs show altered migration and motility in vitro, causing either reduced ( Arhgef2 ) or enhanced ( Rasal3 ) migratory properties. The CCDC88B/RASAL3/ARHGEF2 complex appears to regulate DCs migration by modulating activation of RHOA, with ARHGEF2 and RASAL3 acting in opposite regulatory fashions, providing a molecular mechanism for the involvement of these proteins in DCs immune functions.
biology
What problem does this paper attempt to address?